T
48
3
CMS
60
2
SPG
60
2
AIV
64
4
KMX
61
-3
LRCX
37
-9
MSI
72
-3
LLY
28
-8
GILD
47
-8
TJX
62
-2
NSC
53
-4
M
31
-3
ALL
50
2
AMAT
33
-13
MRK
17
-5
DG
8
-2
APH
65
-3
CCI
30
-11
PCAR
56
-5
IRM
41
3
T
48
3
CMS
60
2
SPG
60
2
AIV
64
4
KMX
61
-3
LRCX
37
-9
MSI
72
-3
LLY
28
-8
GILD
47
-8
TJX
62
-2
NSC
53
-4
M
31
-3
ALL
50
2
AMAT
33
-13
MRK
17
-5
DG
8
-2
APH
65
-3
CCI
30
-11
PCAR
56
-5
IRM
41
3
Financhill
Back

Optica Rare Earths & Critical Matrls ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
38

CRIT
Optica Rare Earths & Critical Matrls ETF

Last Price:
17.75
Seasonality Move:
-0.46%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
38
Optica Rare Earths & Critical Matrls ETF (CRIT) is a Sell

Is Optica Rare Earths & Critical Matrls ETF a Buy, Sell or Hold?

  • The current Optica Rare Earths & Critical Matrls ETF [CRIT] share price is $17.71. The Score for CRIT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRIT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRIT Stock Price Chart

What is Optica Rare Earths & Critical Matrls ETF's stock price today?

  • The Optica Rare Earths & Critical Matrls ETF share price today is $17.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRIT is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CRIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 37.86 Sell
Chaikin Money Flow: 12 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.3 - 19.3) Sell
Bollinger Bands (100): (16.8 - 19.22) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CRIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.36 Sell
20-day SMA: 18.69 Sell
50-day SMA: 18.52 Sell
200-day SMA: 18.36 Sell
8-day EMA: 18.17 Sell
20-day EMA: 18.53 Sell
50-day EMA: 18.48 Sell
200-day EMA: 18.37 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Optica Rare Earths & Critical Matrls ETF Earnings Growth & CRIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Optica Rare Earths & Critical Matrls ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):